FDA to regulate genetic diagnostic tests, will affect cancer testing

Agarose gel with UV illumination Ethidium bromide stained DNA glows orange close up
(Credit: School of Natural Resources from Ann Arbor via Wikimedia Commons)

The Food and Drug Administration unveiled plans to regulate thousands of diagnostic tests, including many coming from the exploding field of genetic research, to which it has until now turned a blind eye.

More than 11,000 of these tests, known as laboratory-developed tests, created by 2,000 different laboratories, could be included in the new regulatory framework, according to the FDA. The agency made its plans public in a guidance document that was sent to Congress, as part of legal direction by legislators.

The FDA’s plan is to enforce regulations based on the amount of risk that a test poses to a patient. Tests that are used to diagnose a disease or to decide on a course of treatment will need to be cleared by the FDA before they can be marketed.

Some tests will be excluded from the new requirements: those used in the treatment of very rare diseases where there is no other test; those that resemble the low-tech tests that FDA originally planned not to regulate; and some tests involved in organ transplants.

But the new policy is likely to have a big impact on the increasingly common practice of using genetics to decide how to treat cancer patients.

Read the full, original story: FDA to regulate thousands of cancer, genetic, and other diagnostics

 

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-11-17-at-12.18.09-PM
Challenging glyphosate fear-mongering: Statewide Nebraska study finds no link between weedkiller use and non-Hodgkin lymphoma
BEMT Lotion for Freckled Skin
Burned by FDA bureaucracy: Why Americans waited decades for cancer-preventing sunscreen
Screenshot-2026-11-17-at-12.56.22-PM
RFK Jr.’s CDC blocked measles risk alert for pregnant women; 112 contracted the disease, and one-quarter were hospitalized
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Crisp Physicians’ Protest Sign Close-Up
‘He’s a disgrace’: Some newly-elected legislators and health groups call for RFK Jr. impeachment 
Screenshot-2026-11-13-at-10.02.02-AM
Viewpoint: Why it’s such a big deal that under Trump-RFK Jr., the U.S. has lost its ‘measles-free’ status  
Nicotine Products on Gray Marble
Comparing vaping, nicotine patches and cigarettes: Not ‘safe vs. dangerous’  but ‘less harmful vs. more harmful’
Split-Toned-Capitol-Healthcare-Rally
Viewpoint: Here’s how Congress can begin to reverse a two-year public health disinformation slide
Screenshot-2026-11-17-at-11.04.14-AM
There are more than 6,000 genetic disorders. For the first time, gene editing is making some treatable. Are we ready?
ChatGPT-Image-Aug-18-2026-12_22_33-PM-2
‘The cure for measles is chicken soup and vitamin A’: Kennedy’s dangerous history of mocking vaccines
Energetic Speaker on Stage
Viewpoint: Why are the stars of the MAHA revolution standing by convicted rapist — and conservative firebrand — Russell Brand?
Screenshot-2026-11-16-at-1.18.40-PM
‘Measles fiasco one of many healthcare failures’: Republican Sen. Bill Cassidy says it's time to fire RFK Jr.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.